Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy

References

• Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 2008;111:5515–5523.
   PubMed Web of Science ®Google Scholar
• Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14:61–70.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010;174:840–850.
   PubMed Web of Science ®Google Scholar
• Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76:20–27.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Kiehna EN, Li C, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys. 2006;65:210–221.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Jain N, Liu W, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro Oncol. 2010;12:1173–1186.
   PubMed Web of Science ®Google Scholar
• Redmond KJ, Mahone EM, Horska A. Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013;15:1455.
   PubMed Web of Science ®Google Scholar
• Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Rev Endocrinol. 2009;5:88–99.
   Web of Science ®Google Scholar
• Mulder RL, Kremer LC, van Santen HM, et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat Rev. 2009;35:616–632.
   PubMed Web of Science ®Google Scholar
• Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. JCO. 2008;26:1112–1118.
   PubMed Web of Science ®Google Scholar
• Scoccianti S, Detti B, Gadda D, et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist’s guide for delineation in everyday practice. Radiother Oncol. 2015;114:230–238.
   PubMed Web of Science ®Google Scholar
• Paulino AC, Lobo M, Teh BS, et al. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010;78:1445–1450.
   PubMed Web of Science ®Google Scholar
• Lee TF, Yeh SA, Chao PJ, et al. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy. Radiat Oncol. 2015;10:194.
   PubMed Web of Science ®Google Scholar
• Mayo C, Martel MK, Marks LB, et al. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76:28–35.
   PubMed Web of Science ®Google Scholar
• Moiseenko V, Wu J, Hovan A, et al. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset. Int J Radiat Oncol Biol Phys. 2012;82:1108–1114.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer. 2002;2:124–132.
   PubMed Web of Science ®Google Scholar
• Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528–1537.
   PubMed Web of Science ®Google Scholar
• Boukheris H, Stovall M, Gilbert ES, et al. Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;85:776–783.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Hua CH, Shukla H, et al. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008;51:110–117.
   PubMed Web of Science ®Google Scholar
• Brower JV, Indelicato DJ, Aldana PR, et al. A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas. Acta Oncol. 2013;52:594–599.
   PubMed Web of Science ®Google Scholar
• Boehling NS, Grosshans DR, Bluett JB, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012;82:643–652.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Vogelius IR, Maraldo MV, et al. Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer 2012;118:5432–5440.
   PubMed Web of Science ®Google Scholar
• Stokkevåg CH, Engeseth GM, Ytre-Hauge KS, et al. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol. 2014;53:1048–1057.
   PubMed Web of Science ®Google Scholar
• Zhang R, Howell RM, Taddei PJ, et al. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol. 2014;113:84–88.
   PubMed Web of Science ®Google Scholar
• Munck af Rosenschold P, Engelholm SA, Brodin PN, et al. A retrospective evaluation of the benefit of referring pediatric cancer patients to an external proton therapy center. Pediatr Blood Cancer. 2016;63:262–269.
   PubMed Web of Science ®Google Scholar
• Weber DC, Habrand JL, Hoppe BS, et al. Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiother Oncol. 2018;128:44–55.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Lambin P, De Ruysscher D, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–273.
   PubMed Web of Science ®Google Scholar
• Haas-Kogan D, Indelicato D, Paganetti H, et al. National Cancer Institute Workshop on proton therapy for children: considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys. 2018;101:152–168.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:10–19.
   PubMed Web of Science ®Google Scholar
• Danish Head and Neck Cancer Group. DAHANCA Radiotherapy Guidelines 2018 [Internet]. Aarhus, Denmark: DAHANCA; [cited 2019 Feb 1]. Available from: https://www.dahanca.dk/
   Google Scholar
• Radiation Therapy Oncology Group. RTOG Contouring Atlases 2019 [Internet]. Philadelphia, PA: RTOG. [cited 2019 Feb 15]. Available from: https://www.rtog.org/CoreLab/ContouringAtlases.aspx
   Google Scholar
• Sun Y, Yu XL, Luo W, et al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol. 2014;110:390–397.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Rose SR, Bosley C, et al. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. JCO. 2011;29:4776–4780.
   PubMed Web of Science ®Google Scholar
• Jalali R, Mallick I, Dutta D, et al. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2010;77:974–979.
   PubMed Web of Science ®Google Scholar
• Zureick AH, Evans CL, Niemierko A, et al. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer 2018;124:2238–2245.
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123–135.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.
   PubMed Web of Science ®Google Scholar
• Houweling AC, Philippens ME, Dijkema T, et al. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2010;76:1259–1265.
   PubMed Web of Science ®Google Scholar
• Schneider U, Sumila M, Robotka J. Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model. 2011;8:27.
   PubMed Web of Science ®Google Scholar
• King MT, Modlin L, Million L, et al. The parotid gland is an underrecognized organ at risk for craniospinal irradiation. Technol Cancer Res Treat. 2016;15:472–479.
   PubMed Web of Science ®Google Scholar
• Teoh M, Clark CH, Wood K, et al. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84:967–996.
   PubMed Web of Science ®Google Scholar
• Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319:1033–1039.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Cancer risks from CT scans: now we have data, what next? Radiology 2012;265:330–331.
   PubMed Web of Science ®Google Scholar
• Pediatric Proton/Photon Consortium Registry (PPCR) 2019 [Internet]. [cited 2019 Mar 1]. Available from: http://www.pedsprotonregistry.org/
   Google Scholar
• Pixberg C, Koch R, Eich HT, et al. Acute toxicity grade 3 and 4 after irradiation in children and adolescents: results from the IPPARCA collaboration. Int J Radiat Oncol Biol Phys. 2016;94:792–799.
   PubMed Web of Science ®Google Scholar
• Grau C, Baumann M, Weber DC. Optimizing clinical research and generating prospective high-quality data in particle therapy in Europe: Introducing the European Particle Therapy Network (EPTN). Radiother Oncol. 2018;128:1–3.
   PubMed Web of Science ®Google Scholar
• Pediatric Normal Tissue Effects in the Clinic (PENTEC). 2019. [cited 2019 Jan 3]. Available from: https://www.pentecradiation.org
   Google Scholar
• Rorvik E, Fjaera LF, Dahle TJ, et al. Exploration and application of phenomenological RBE models for proton therapy. Phys Med Biol. 2018;63:185013.
   PubMed Web of Science ®Google Scholar
• Fjæra LF, Li Z, Ytre-Hauge KS, et al. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. Acta Oncol. 2017;56:763–768.
   PubMed Web of Science ®Google Scholar